medline.ch Gastroenterologie Magen-Darm Neoplasie

	Intraperitoneal blue LED irradiation as a potential approach to suppress gastric cancer peritoneal dissemination in a murine model. Sci Rep Kai K, Ishizuka T, Matsumoto J, Shimamawari K, Lkham-Erdene B, Kubota T, Oo PS, Aung KM, Matsui H, Ikenoue M, Nanashima A, Hishikawa Y. PMID: 42270921 [PubMed - as supplied by publisher]
	Synthesis, biological evaluation and detailed computational studies of N-sulfonyl indole-based dihydrothiazoles against colorectal carcinoma. Sci Rep Batool Z, Naseer I, Ate, Çak, Akba, Albekairi NA, , Rasool A, Shafiq Z, Alshammari A. PMID: 42270895 [PubMed - as supplied by publisher]
	Defying inflammation-driven early-onset colorectal cancer: predict, prevent, and personalize. Trends Cancer Samuel TM, Samuel SM, Varghese E, Sreenesh B, Büsselberg D. PMID: 42270509 [PubMed - as supplied by publisher]
	NRG-GI007: Phase I study of OBP-301, an oncolytic virus, and definitive chemoradiation in locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys Ku GY, Winter K, Ilson D, Adusumilli PS, Nishimura M, Yock AD, Mehta RJ, Biran T, Frakes JM, Wu A, Miller ED, Klempner SJ, Moughan J, Hong TS, Williams TM. PMID: 42269787 [PubMed - as supplied by publisher]
	Effect of [(68)Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial. Lancet Oncol Buteau JP, Moon D, Fahey MT, Roberts MJ, Ayati N, Papa N, Murphy DG, Kasivisvanathan V, Dhillon HM, Du YT, Dundee P, Foudoulis J, Hennes D, Hutton AC, Idiare J, Jack G, Kamath S, Lee SN, Lee SF, Lee ST, Leslie S, Levy SM, Link E, Mitchell C, Morigi JJ, Nguyen A, Olphert J, Patel MI, Pattison DA, Pearce A, Perera M, Thanigasalam R, Thomson A, Yaxley J, Thompson J, Hofman MS, Emmett L, PRIMARY2 Trial Investigators. PMID: 42269655 [PubMed - as supplied by publisher]
	Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis. ESMO Open Raimondi A, Tinè G, Boige V, De Stefano A, Ballhausen A, Gourgou S, Giuliani F, Stahler A, Randon G, Prisciandaro M, Manca P, Ambrosini M, Fazio R, Mohamed S, Gronchi G, Santabarbara G, Brument E, Alig AHS, Miceli R, Bouche O, Modest DP, Avallone A, Pietrantonio F. PMID: 42269232 [PubMed - as supplied by publisher]
	Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity. J Urol George A, Giesler E, Mazzarella B, Levin R, Frendl D, Warlick C, Given R, Kella N, Frye T, Mynderse L, Kasraeian A, Milbank A, Nabbout P, Grunberger I, Rastinehad A, Schwartz M, Wysock J, Rousseau M, Pliskin M, Satkunasivam R, Rich D, Shore ND, Moreno J, Belkoff L, Sidana A, Taneja SS. PMID: 42269147 [PubMed - as supplied by publisher]
	State-level burden of early onset colorectal cancer in the US: a Global Burden of Disease study, 1980 to 2021. Proc (Bayl Univ Med Cent) Suenghataiphorn T, Tangpradubkiat P, Prasitsumrit V, Kulthamrongsri N, Danpanichkul P, Singhania R. PMID: 42269057 [PubMed - indexed for MEDLINE]
	Impact of tumor budding on recurrence risk prediction in stage I-III colorectal cancer: a Swedish cohort study. Am J Clin Pathol Barot S, Andersson-Franko M, Ghazi S, Lindforss U, Rantanen P, Blom J, Lindblom A, Liljegren A. PMID: 42268999 [PubMed - in process]
	Type 2 diabetes and cancer: A retrospective longitudinal comparative cohort study of disease sequence and comorbidity profiles. PLoS One Alriyami M, Malehi AS, Al Kamyani A, Al Jabri F, Alhosni M, Al Saadi K, Al-Maqbali S, Al-Shuaili TK, Al-Futaisi A. PMID: 42268817 [PubMed - in process]
	The impact of the PI3K/AKT/mTOR signaling pathway on trastuzumab resistance in HER2-positive gastric cancer. Clin Transl Oncol Salehi A, Piccaluga PP. PMID: 42268566 [PubMed - as supplied by publisher]
	A mixed-method study of identifying symptom clusters in adult patients with advanced cancer. Support Care Cancer Miladinia M, Zarea K, Gheibizadeh M, Jahangiri M, Karimpourian H, Rokhafroz D. PMID: 42268436 [PubMed - indexed for MEDLINE]
	MRI versus histopathology in EMVI detection for rectal cancer: prognostic relevance and survival outcomes. Eur Radiol Lunder AK, Meltzer S, Frøyen EA, Lyckander LG, Grandal OJ, Ree AH, Redalen KR, Negård A. PMID: 42268308 [PubMed - as supplied by publisher]
	The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers predict the risk of colorectal cancer: A case-control study. Cancer Biomark Karami R, Najafi E, Babaei A, Shahdoust E, Shaghaghi A, Amiri-Dashatan N, Motlagh B, Koushki M, Khodabandehloo H. PMID: 42267882 [PubMed - indexed for MEDLINE]
	Host-microbiome interactions in breast cancer progression and treatment response. Front Med (Lausanne) Bautista J, Lara-Hernández ME, Hidalgo-De La Cruz M, Andino-Araque V, León-Rivera M, López-Cortés A. PMID: 42266934 [PubMed]
	Hematological biomarkers for predicting pathologic response to neoadjuvant immunochemotherapy and cycle optimization in locally advanced gastric cancer. Front Immunol Lu X, Cui X, Chen H, Zhang J, Zhao S, Yang B, Yang Y, Du N, Ma W, An J, Yu Y. PMID: 42266698 [PubMed - in process]
	Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms. Front Immunol Lu X, Gan W, Yuan J, Chen Z. PMID: 42266677 [PubMed - in process]
	Commentary: Development and validation of a multivariate predictive model for cancer-related fatigue in esophageal carcinoma: a prospective cohort study integrating biomarkers and psychosocial factors. Front Oncol Sedighi S. PMID: 42266670 [PubMed]
	The international and domestic research trends of targeted therapy in bladder cancer: a bibliometric analysis of the past three decades. Front Oncol Pan Y, Sun Y, Jiao B, Zhang Y, Zhang G. PMID: 42266656 [PubMed]
	Role of Repeat Preoperative Endoscopy in Colorectal Cancer: Patients' Perspectives. Cureus Cloutier Z, Johnson G, Shanahan J, Hallock D, Shariff F, Hyun E, Singh H, Helewa RM. PMID: 42266300 [PubMed]

Artikel 1 - 20 / 240678

Seite 1 von 12034



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung